Systematic review of clinical practice guidelines in the diagnosis and management of thyroid nodules and cancer

BMC Medicine

Ka-Wai Tam¹  Chih-Hsiung Wu⁴  Shiah-Lian Chen²  Mei-Yi Wu⁵  Jun-Hung Lai³  Tsai-Wei Huang² 

[1] Evidence-based Medicine Center, Taipei Medical University Hospital, 252 Wu-Hsing Street, Taipei 11031, Taiwan;Department of Nursing, College of Medicine and Nursing, Hung Kuang University, Taichung, Taiwan;Department of Internal Medicine, Erlin Branch of Changhua Christian Hospital, Taichung, Taiwan;Division of General Surgery, Department of Surgery, Taipei Medical University - Shuang Ho Hospital, Taipei, Taiwan;Center for Evidence-based Health Care, Taipei Medical University - Shuang Ho Hospital, Taipei, Taiwan

关键词: Systematic review;    Thyroid nodule;    Thyroid cancer;    Clinical practice guidelines;   

Others  :  855735
DOI  :  10.1186/1741-7015-11-191

 received in 2013-06-05, accepted in 2013-07-31,  发布年份 2013

【 摘 要 】

Background

Given the uncertainties regarding thyroid nodule assessment and management, physicians require systematically and transparently developed recommendations. This systematic review assesses the quality and consistency of the recommendations of international clinical practice guidelines (CPGs) for the diagnosis and management of thyroid nodules and cancer to assist physicians in making appropriate recommendations.

Methods

The CPGs on the management of thyroid nodules and cancer published before June 2013 were retrieved. All the reviewed guidelines were in English. Four reviewers independently assessed the rigor of guideline development by using the Appraisal of Guidelines Research and Evaluation II (AGREE-II) instrument, and their reported evidence was evaluated.

Results

Ten eligible guidelines were included: nine had been developed by professional organizations, and the remaining guideline was endorsed by an independent regional body. Three guidelines achieved a score of greater than 50% in all six AGREE-II domains. Guidelines scored highest on the measurement of ‘scope and purpose’ (≥61.1% for eight CPGs) and lowest on the measurement of ‘applicability’ (≤38.5% for five CPGs). The overall quality ranged from 3.0 to 6.25 on a seven-point scale on the AGREE-II tool. Most CPG recommendations on the management of thyroid cancer were relatively consistent. Guidelines varied regarding the indication of fine-needle aspiration for thyroid nodules, as well as in their suggestions for postoperative radioiodine ablation.

Conclusions

Our analysis showed that the current CPGs varied in methodological quality. More effort is needed to improve the quality of recommendations on the diagnosis and management of thyroid nodules and cancer.

【 授权许可】

   
2013 Huang et al.; licensee BioMed Central Ltd.

【 图 表 】

【 参考文献 】

• [1]Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, Evans JG, Young E, Bird T, Smith PA: The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 1977, 7:481-493.
• [2]Vander JB, Gaston EA, Dawber TR: The significance of nontoxic thyroid nodules. Final report of a 15-year study of the incidence of thyroid malignancy. Ann Intern Med 1968, 69:537-540.
• [3]Hegedüs L: Clinical practice. The thyroid nodule. N Engl J Med 2004, 351:1764-1771.
• [4]Mandel SJ: A 64-year-old woman with a thyroid nodule. JAMA 2004, 292:2632-2642.
• [5]Coleman MP, Estève J, Damiecki P, Arslan A, Renard H: Trends in cancer incidence and mortality. IARC Sci Publ 1993, 121:1-806.
• [6]Sherman SI: Thyroid carcinoma. Lancet 2003, 361:501-511.
• [7]Grilli R, Magrini N, Penna A, Mura G, Liberati A: Practice guidelines developed by specialty societies: the need for a critical appraisal. Lancet 2000, 355:103-106.
• [8]Graham ID, Harrison MB: Evaluation and adaptation of clinical practice guidelines. Evid Based Nurs 2005, 8:68-72.
• [9]Oxman AD, Glasziou P, Williams JW Jr: What should clinicians do when faced with conflicting recommendations? BMJ 2008, 337:a2530.
• [10]The AGREE Research Trust: Appraisal of Guidelines for Research and Evaluation II Instrument. In Edited by Brouwers MC. 2009. Available: http://www.agreetrust.org webcite. Accessed August 2012
• [11]Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers B, Graham ID, Grimshaw J, Hanna S, Littlejohns P, Makarski J, Zitzelsberger L: for the AGREE Next Steps Consortium. AGREE II: Advancing guideline development, reporting and evaluation in healthcare. Can Med Assoc J 2010, 182:839-842.
• [12]Qaseem A, Snow V, Shekelle P, Hopkins R Jr, Owens DK: Screening for HIV in health care settings: a guidance statement from the American College of Physicians and HIV Medicine Association. Ann Intern Med 2009, 150:125-131.
• [13]Sinuff T, Patel RV, Adhikari NK, Meade MO, Schünemann HJ, Cook DJ: Quality of professional society guidelines and consensus conference statements in critical care. Crit Care Med 2008, 36:1049-1058.
• [14]Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Hegedüs L, Vitti P: American association of clinical endocrinologists, associazione Medici endocrinologi, and European thyroid association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. J Endocrinol Invest 2010, 33:1-50.
• [15]Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM, American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer: Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009, 19:1167-1214.
• [16]The British Thyroid Association and the Royal College of Physicians: Guidelines for the Management of Thyroid Cancer. 2nd edition. 2007. Available: http://www.british-thyroid-association.org webcite
• [17]Pacini F, Castagna MG, Brilli L, Pentheroudakis G, ESMO Guidelines Working Group: Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2012, 23:vii110-119.
• [18]Dralle H, Musholt TJ, Schabram J, Steinmüller T, Frilling A, Simon D, Goretzki PE, Niederle B, Scheuba C, Clerici T, Hermann M, Kußmann J, Lorenz K, Nies C, Schabram P, Trupka A, Zielke A, Karges W, Luster M, Schmid KW, Vordermark D, Schmoll HJ, Mühlenberg R, Schober O, Rimmele H, Machens A, German Societies of General and Visceral Surgery; Endocrinology; Nuclear Medicine; Pathology; Radiooncology; Oncological Hematology; and the German Thyroid Cancer Patient Support Organization Ohne Schilddrüse leben e.V: German association of endocrine surgeons practice guideline for the surgical management of malignant thyroid tumors. Langenbecks Arch Surg 2013, 398:347-375.
• [19]Comprehensive Cancer Centre, The Netherlands: Thyroid Carcinoma (English version). National Evidence-Based Guideline. Version:1.0. 2007. Available: http://www.oncoline.nl webcite
• [20]Pitoia F, Ward L, Wohllk N, Friguglietti C, Tomimori E, Gauna A, Camargo R, Vaisman M, Harach R, Munizaga F, Corigliano S, Pretell E, Niepomniszcze H: Recommendations for the Latin American Thyroid Society on diagnosis and management of differentiated thyroid cancer. Arq Bras Endocrinol Metabol 2009, 53:884-887.
• [21]National Cancer Comprehensive Network (NCCN Guidelines): Thyroid carcinoma. Version 2. 2013. Available: http://www.nccn.org webcite
• [22]Regional Thyroid Cancer Group: Northern Cancer Network guidelines for management of thyroid cancer. Clin Oncol (R Coll Radiol) 2000, 12:373-391.
• [23]Martínez Trufero J, Capdevilla J, Cruz JJ, Isla D: SEOM clinical guidelines for the treatment of thyroid cancer. Clin Transl Oncol 2011, 13:574-579.
• [24]Shekelle P, Eccles MP, Grimshaw JM, Woolf SH: When should clinical guidelines be updated? BMJ 2001, 323:155-157.
• [25]Shekelle PG, Ortiz E, Rhodes S, Morton SC, Eccles MP, Grimshaw JM, Woolf SH: Validity of the agency for healthcare research and quality clinical practice guidelines: how quickly do guidelines become outdated? JAMA 2001, 286:1461-1467.
• [26]The ADAPTE Collaboration: The ADAPTE Process: Resource Toolkit for Guideline Adaptation. 2nd edition. 2009. Available: http://www.adapte.org webcite
• [27]Al-Ansary LA, Tricco AC, Adi Y, Bawazeer G, Perrier L, Al-Ghonaim M, AlYousefi N, Tashkandi M, Straus SE: A systematic review of recent clinical practice guidelines on the diagnosis, assessment and management of hypertension. PLoS One 2013, 8:e53744.
• [28]Campbell F, Dickinson HO, Cook JV, Beyer FR, Eccles M, Mason JM: Methods underpinning national clinical guidelines for hypertension: describing the evidence shortfall. BMC Health Serv Res 2006, 6:47. BioMed Central Full Text
• [29]Bilimoria KY, Bentrem DJ, Ko CY, Stewart AK, Winchester DP, Talamonti MS, Sturgeon C: Extent of surgery affects survival for papillary thyroid cancer. Ann Surg 2007, 246:375-381.
• [30]Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers B, Graham ID, Grimshaw J, Hanna SE, Littlejohns P, Makarski J, Zitzelsberger L: The Global Rating Scale complements the AGREE II in advancing the quality of practice guidelines. J Clin Epidemiol 2012, 65:526-534.